Metabolic Research
Tirzepatide (40mg)
Research Tirzepatide vial, dispatched from Australian stock. In Stock
$279.99AUD, GST inclusive · $7.00 per mg
CoA on request40mg per vialLyophilised powderSame business day dispatch*
Other sizes
| Product | Price | Per mg | Stock |
|---|---|---|---|
| Tirzepatide (20mg) | $249.99 | $12.50/mg | In Stock |
| Tirzepatide (40mg) | $279.99 | $7.00/mg | In Stock |
| Tirzepatide (60mg) | $349.99 | $5.83/mg | In Stock |
Dual GIP and GLP-1 receptor agonist
Tirzepatide is a 39-amino-acid peptide that activates both the GIP and GLP-1 receptors. It is the first dual incretin agonist to complete Phase 3 development and is registered in many countries as a prescription medicine. The research-grade vial supplied here is the unformulated peptide for laboratory use, not the branded pen.
The 40mg vial sits between the 20mg and 60mg formats at $7.00/mg. It suits mid-length protocols that would outgrow the smaller vial without needing the largest.
The full research summary, mechanism and legal status are on the Tirzepatide page.
Key research areas
- Glycaemic control — HbA1c and fasting glucose across the SURPASS trials
- Body composition — Fat mass versus lean mass in DEXA sub-studies
- Appetite signalling — Food intake and satiety measures in Phase 1 pharmacology
- Hepatic fat — Liver-fat fraction by MRI-PDFF in MASLD studies
- Cardiovascular outcomes — SURPASS-CVOT and SUMMIT programs
Also known as: LY3298176, Tirz, tirz, tirzeptide, Mounjaro (brand), Zepbound (brand)
Certificate of analysis. Every batch carries a certificate from an independent laboratory. Request the certificate for your batch with your order number and we send it.
Specifications
- Compound
- Tirzepatide
- CAS number
- 2023788-19-2
- Category
- Metabolic Research
- Vial size
- 40mg
- Certificate of analysis
- Available on request
- Form
- Lyophilised powder
- Suggested reconstitution
- 2 mL bacteriostatic water
- Storage (lyophilised)
- −20 °C, protect from light and moisture
- Storage (reconstituted)
- 2–8 °C, use within 8–12 weeks
- SKU
- PEP-021-40MG
Reconstitution calculator for this vial
Full calculator →For in-vitro research and laboratory use only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws.
Frequently asked questions
How do you reconstitute Tirzepatide (40mg)?
Add about 2 mL of bacteriostatic water slowly down the inside of the vial and swirl gently; do not shake. 40mg in 2 mL gives 20 mg/mL. Refrigerate at 2–8 °C after reconstitution and use within 8–12 weeks. The calculator has this vial preset.
How should Tirzepatide be stored?
Lyophilised: −20 °C, sealed, away from light and moisture. Reconstituted: 2–8 °C, used within 8–12 weeks, never frozen.
Is Tirzepatide legal in Australia?
Tirzepatide is a Schedule 4 prescription-only medicine in Australia when supplied as the registered product. Research-grade tirzepatide powder is not that product and is not approved for human use. Peptide Aus supplies it for in-vitro laboratory research only.
Where can I buy Tirzepatide in Australia, and what does it cost?
Directly from Peptide Aus, from Australian stock, in 3 vial sizes from $249.99 (20mg) to $349.99 (60mg). Prices are AUD and GST inclusive. Paid orders before 2pm AEST/AEDT dispatch the same business day, tracked.
Frequently bought together
